These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1636538)

  • 1. MR of primary CNS lymphoma in immunologically normal patients.
    Roman-Goldstein SM; Goldman DL; Howieson J; Belkin R; Neuwelt EA
    AJNR Am J Neuroradiol; 1992; 13(4):1207-13. PubMed ID: 1636538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients.
    Coulon A; Lafitte F; Hoang-Xuan K; Martin-Duverneuil N; Mokhtari K; Blustajn J; Chiras J
    Eur Radiol; 2002 Feb; 12(2):329-40. PubMed ID: 11870430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.
    Yap KK; Sutherland T; Liew E; Tartaglia CJ; Pang M; Trost N
    J Med Imaging Radiat Oncol; 2012 Apr; 56(2):179-86. PubMed ID: 22498191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary intracranial CNS lymphoma: MR manifestations.
    Schwaighofer BW; Hesselink JR; Press GA; Wolf RL; Healy ME; Berthoty DP
    AJNR Am J Neuroradiol; 1989; 10(4):725-9. PubMed ID: 2505501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system lymphoma: magnetic resonance imaging features at presentation.
    Schwingel R; Reis F; Zanardi VA; Queiroz LS; França MC
    Arq Neuropsiquiatr; 2012 Feb; 70(2):97-101. PubMed ID: 22311212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features.
    Johnson BA; Fram EK; Johnson PC; Jacobowitz R
    AJNR Am J Neuroradiol; 1997 Mar; 18(3):563-72. PubMed ID: 9090424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system lymphoma in children.
    Porto L; Kieslich M; Schwabe D; Yan B; Zanella FE; Lanfermann H
    Pediatr Hematol Oncol; 2005; 22(3):235-46. PubMed ID: 16020108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
    Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
    Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI features of CNS lymphoma in dogs and cats.
    Palus V; Volk HA; Lamb CR; Targett MP; Cherubini GB
    Vet Radiol Ultrasound; 2012; 53(1):44-9. PubMed ID: 22093168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system lymphoma.
    Ginat DT; Purakal A; Pytel P
    J Neurooncol; 2015 Nov; 125(2):297-305. PubMed ID: 26341369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSL.
    Farrell BT; Hamilton BE; Dósa E; Rimely E; Nasseri M; Gahramanov S; Lacy CA; Frenkel EP; Doolittle ND; Jacobs PM; Neuwelt EA
    Neurology; 2013 Jul; 81(3):256-63. PubMed ID: 23771486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal hepatic lymphoma: magnetic resonance demonstration using current techniques including gadolinium enhancement.
    Kelekis NL; Semelka RC; Siegelman ES; Ascher SM; Outwater EK; Woosley JT; Reinhold C; Mitchell DG
    Magn Reson Imaging; 1997; 15(6):625-36. PubMed ID: 9285802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Evaluation in Primary CNS Lymphoma.
    Lukas RV; Riedell P; Horowitz PM; Pytel P; Kamson DO
    Neurologist; 2018 Mar; 23(2):53-54. PubMed ID: 29494436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of perfusion weighted image of CNS lymphoma.
    Lee IH; Kim ST; Kim HJ; Kim KH; Jeon P; Byun HS
    Eur J Radiol; 2010 Oct; 76(1):48-51. PubMed ID: 19500931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of Enhancing Glioma and Primary Central Nervous System Lymphoma by Texture-Based Machine Learning.
    Alcaide-Leon P; Dufort P; Geraldo AF; Alshafai L; Maralani PJ; Spears J; Bharatha A
    AJNR Am J Neuroradiol; 2017 Jun; 38(6):1145-1150. PubMed ID: 28450433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary hamartomas: solitary and multiple lesions shown on current MR techniques including gadolinium enhancement.
    Semelka RC; Hussain SM; Marcos HB; Woosley JT
    J Magn Reson Imaging; 1999 Aug; 10(2):196-201. PubMed ID: 10441025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical radiological findings of primary central nervous system lymphoma.
    Lin X; Khan IRA; Seet YHC; Lee HY; Yu WY
    Neuroradiology; 2020 Jun; 62(6):669-676. PubMed ID: 32077984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Combined Performance of ADC, CSF CXC Chemokine Ligand 13, and CSF Interleukin 10 in the Diagnosis of Central Nervous System Lymphoma.
    Mabray MC; Barajas RF; Villanueva-Meyer JE; Zhang CA; Valles FE; Rubenstein JL; Cha S
    AJNR Am J Neuroradiol; 2016 Jan; 37(1):74-9. PubMed ID: 26381553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristic imaging features of primary central nervous system lymphoma in comparison with pathological findings].
    Liu HY; Zhang XL; Chen YP; Qiu SJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):333-6. PubMed ID: 19246316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermetabolic change as a possible predictive sign of a relapsed central nervous system lymphoma.
    Nakahara T; Takagi Y; Shiga H; Uchida H; Kaburaki J; Kubo A
    Clin Nucl Med; 2007 Feb; 32(2):87-9. PubMed ID: 17242558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.